Nearly 20% of new moms have anxiety or depression, but a promising psychedelic treatment is on the horizon
A new psychedelic treatment called luvesilocin is showing promise in clinical trials for treating postpartum depression and anxiety. Researchers believe this drug could offer rapid relief for conditions that currently affect nearly 20% of new mothers.
Women with postpartum depression and anxiety have a higher risk of birth complications and death by suicide. Justin Paget/DigitalVision via Getty Images Nearly 20% of new moms have anxiety or depression, but a promising psychedelic treatment is on the horizon Published: July 7, 2026 8:15am EDT https://theconversation.com/nearly-20-of-new-moms-have-anxiety-or-depression-but-a-promising-psychedelic-treatment-is-on-the-horizon-283028 https://theconversation.com/nearly-20-of-new-moms-have-anxiety-or-depression-but-a-promising-psychedelic-treatment-is-on-the-horizon-283028 Link copied Share article Share article
Get the full story
Sign up for Headlinne to unlock AI insights, political bias analysis, and your personalized news feed.
Create free accountAlready have an account? Sign in